Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03955289 · ClinicalTrials.gov registry record
Treatment of Foot and Leg Ulcers Using a Laser
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 34
- Enrollment target
NCT03955289: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT03955289 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03955289 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The investigators plan to do a retrospective chart review on patients who underwent laser treatment for their foot ulcer at the UT Southwestern wound clinic.
Primary Outcome
Wounds assessed in this study will show significant improvement in wound characteristics after Erbium-YAG laser debridement(s). Improved healing rate to time to healing.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-01-15 |
| Est. Completion | 2019-02-01 |
What the finished NCT03955289 record still lists
NCT03955289 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03955289 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03955289 about?
NCT03955289 is a clinical study titled "Treatment of Foot and Leg Ulcers Using a Laser". The investigators plan to do a retrospective chart review on patients who underwent laser treatment for their foot ulcer at the UT Southwestern wound clinic.
What is the current status of trial NCT03955289?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2019-01-15. Estimated completion is 2019-02-01.
Who is sponsoring clinical trial NCT03955289?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI